Skip to main content
TipRanks
Go Ultimate75% OFF

Heron Therapeutics (AXD2) Q4 2025 Earnings Report

4 Followers

DE:AXD2 Q4 2025 EPS Results

Actual EPS
-EUR 0.02
Consensus EPS
-EUR 0.02
Beat/Miss
Met expectations
One Year Ago EPS
EUR 0.02

DE:AXD2 Q4 2025 Revenue Results

Actual Revenue
EUR 36.82M
Expected Revenue
EUR 36.17M
Beat/Miss
Beat by +EUR 654.13K
YoY Revenue Growth
-0.47%

Earnings Announcement Details

Quarter
Q4 2025
Date
02/26/2026
Time
Before Open
Conference Call
Thursday, February 26, 2026
DE:AXD2 Upcoming Earnings

Heron Therapeutics's next earnings date is estimated for March 4, 2027, based on past reporting schedules.

Q4 2025 Earnings Call Audio

DE:AXD2 Q4 2025 Earnings Call
0:00 / 0:00

Q4 2025 Earnings Slide Deck

Q4 2025 Earnings Call Summary

No earnings call summary is available for this earnings event.

DE:AXD2 Earnings History

DE:AXD2 earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 04, 20272026 (Q4)-0.03--0.02――
Nov 09, 20262026 (Q3)-0.02-0.03-0.0970.00% (+0.06)
Aug 10, 20262026 (Q2)-0.00-0.03-0.02-50.00% (-0.01)
May 11, 20262026 (Q1)-0.02-0.040.01-500.00% (-0.05)
Feb 26, 20262025 (Q4)-0.02-0.020.02-200.00% (-0.04)
Nov 04, 20252025 (Q3)-0.01-0.09-0.03-233.33% (-0.06)
Aug 08, 20252025 (Q2)-0.01-0.02-0.0566.67% (+0.04)
May 06, 20252025 (Q1)-0.010.01-0.02150.00% (+0.03)
Feb 27, 20252024 (Q4)-0.030.02-0.06128.57% (+0.08)
Nov 12, 20242024 (Q3)-0.03-0.03-0.1582.35% (+0.13)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed